G1 Therapeutics Inc

NASDAQ:GTHX   3:59:51 PM EDT
4.73
+0.06 (+1.28%)
Earnings Announcements

G1 Therapeutics Provides First Quarter 2022 Financial Results

Published: 05/04/2022 13:14 GMT
G1 Therapeutics Inc (GTHX) - G1 Therapeutics Provides First Quarter 2022 Financial Results and Operational Highlights.
Q1 Loss per Share $1.15.
Q1 Revenue $6.9 Million.
Expects Current Cash Position of $183.0 Million to Be Sufficient to Fund Its Operations and Capital Expenditures Into 2024.
Revenue is expected to be $9.15 Million
Adjusted EPS is expected to be -$1.02

Next Quarter Revenue Guidance is expected to be $11.97 Million
Next Quarter EPS Guidance is expected to be -$0.92

More details on our Analysts Page.